Proteomics

Dataset Information

0

Non-viral in situ gene editing effectively and safely rescues congenital ichthyosis-causing mutations in human skin


ABSTRACT: Autosomal recessive congenital ichthyosis (ARCI) refers to a group of rare, highly debilitating skin disorders which significantly impair patients’ quality of life and lack any effective treatment options. Here, we report clinically-relevant in situ correction of the most common ARCI-causing mutation TGM1 c.877-2A>G, a splice-site aberration, in human disease models. Targeted skin barrier modulation followed by topical application of the cytosine base editor eTD packaged into lipid nanoparticles yielded functional restoration of ~30% of wild-type transglutaminase 1 activity in skin tissue. Toxicity studies and comprehensive off-target analysis demonstrated an excellent safety profile even after repeated application, without systemic distribution of the lipid nanoparticles or the genetic cargo as determined via highly-sensitive methods including DESI metabolic imaging. This study presents comprehensive preclinical data on the feasibility of in situ gene correction of genodermatoses-causing mutations showcasing its therapeutic potential and paving the way for curative next-generation treatments for severe genetic skin diseases.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Skin

DISEASE(S): Autosomal Recessive Congenital Ichthyosis

SUBMITTER: Fabian Coscia  

LAB HEAD: Fabian Coscia

PROVIDER: PXD072230 | Pride | 2026-01-23

REPOSITORIES: Pride

Similar Datasets

2025-08-27 | PXD064019 | Pride
2023-10-10 | PXD044714 | Pride
2025-10-27 | PXD064497 | Pride
2025-02-19 | PXD054440 | Pride
2025-11-12 | PXD066874 | Pride
2025-06-30 | PXD055852 | Pride
2025-12-19 | PXD062231 | Pride
2026-01-21 | PXD069027 | Pride
2025-10-20 | PXD057183 | Pride
2026-01-15 | PXD059920 | Pride